&lt;Advanced Viral Research 
Corp> said its facility to manufacture reticulose, an anti-
viral agent, is ready for FDA inspection.
    The company said it will make a formal request for the
review by the end of March.
    The company said if the facility is approved, initial tests
and trials on AIDS patients will start soon afterward.
 Reuter
&#3;